SFT — Sopharma Trading AD Balance Sheet
0.000.00%
- BGN193.06m
 - BGN472.80m
 - BGN1.96bn
 
- 68
 - 99
 - 71
 - 96
 
Annual balance sheet for Sopharma Trading AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.12 | 11.7 | 6.83 | 13.1 | 13.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 236 | 209 | 210 | 242 | 282 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 438 | 415 | 416 | 488 | 597 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 114 | 106 | 111 | 114 | 139 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 617 | 583 | 573 | 643 | 803 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 444 | 401 | 379 | 435 | 513 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 540 | 498 | 478 | 520 | 641 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 76.9 | 84.9 | 94.5 | 123 | 162 | 
| Total Liabilities & Shareholders' Equity | 617 | 583 | 573 | 643 | 803 | 
| Total Common Shares Outstanding |